REGULATORY

Chuikyo Submits Recommendation for FY2016 Reimbursement Policy Reform, New Generic Incentive for Clinics Already Questioned

February 12, 2016

- Only subscribers can save articles.
  
  Sign In
  
  Subscribe

The Central Social Insurance Medical Council (Chuikyo) submitted its recommendation for the FY2016 reimbursement policy reform to the health minister on February 10, proposing boosted incentives for generic use, but the effectiveness of a new fee system for clinics has…

To read the full story

Chuikyo OKs Basic Plan for Pilot-Based HTA Scheme; Sovaldi, Opdivo Emerge as Likely Candidates
February 12, 2016

REGULATORY

Panel to Weigh Orphan Designation for Tecartus on December 22
December 17, 2025
LDP League Formally Urges Male HPV Shots Under NIP from FY2026
December 17, 2025
Solo Distribution Poses Threats to Stable Supplies, Price Negotiations: Survey
December 17, 2025
MHLW Drafts Guideline Update, Urges Makers to Factor Distribution Costs into WPPs
December 16, 2025
MHLW to Add Company-Driven Route to “Specific-Use Drug” Designations
December 16, 2025

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo Backs Draft FY2026 Pricing Reform Outline, Rejects Key Industry Requests

By Takashi Ebisawa

The Ministry of Health, Labor and Welfare (MHLW) on December 12 presented a draft outline of the FY2026 drug pricing…

COMMENTARY

FY2026 Reform Debate for Drug Pricing Nears the Finish Line, Balance Needed

By Takashi Ebisawa

Japan has presented its latest draft policy direction for its FY2026 drug pricing reform. While the package includes a string…

COLUMN

AI in HR: Navigating the Ethical Minefield

By Philip Carrigan

Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…